Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 61-67, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El Kassar, N.
Right arrow Articles by Grandchamp, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El Kassar, N.
Right arrow Articles by Grandchamp, B.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 1998;44:61-67.)
© 1998 American Association for Clinical Chemistry, Inc.


Molecular Pathology and Genetics

X-Chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms

Nahed El Kassara, Gilles Hetet, Jean Brière, and Bernard Grandchamp

a Author for correspondence. Fax 33 1 42 26 46 24; e-mail U409{at}bichat.inserm.fr.

Skewed lyonization in healthy females represents the major disadvantage of X-chromosome-based clonality assays. Because most techniques are based on the difference in DNA methylation between active and inactive X-chromosomes, incomplete DNA digestion may occur, giving an unreliable clonality result. Here, we compare two different techniques carried out in healthy females belonging to three age groups and in a group of patients with essential thrombocythemia. The first technique involved the human androgen receptor gene, the second the transcript analysis of the iduronate-2-sulfatase, P55, and glucose-6-phospate dehydrogenase genes. Results between both techniques were concordant in most cases except in neonates, and the same pattern was observed in all fractions in healthy females. We conclude that: (a) clonality assays involving DNA and RNA polymorphisms are usually concordant except in neonates; (b) appropriate control tissue embryologically related to the sample must be chosen to eliminate excessive lyonization; (c) acquired skewing increases with age, whereas nonrandom lyonization is a rare phenomenon.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Mol. Diagn.Home page
M. Boudewijns, J. J.M. van Dongen, and A. W. Langerak
The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations
J. Mol. Diagn., July 1, 2007; 9(3): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Kralovics, S.-S. Teo, S. Li, A. Theocharides, A. S. Buser, A. Tichelli, and R. C. Skoda
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
Blood, August 15, 2006; 108(4): 1377 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. M. Watson, G. J. Pelka, T. Radziewic, M. D. Shahbazian, J. Christodoulou, S. L. Williamson, and P. P.L. Tam
Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation
Hum. Mol. Genet., July 1, 2005; 14(13): 1851 - 1861.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Liu, J. Jelinek, Y. D. Pastore, Y. Guan, J. F. Prchal, and J. T. Prchal
Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin
Blood, April 15, 2003; 101(8): 3294 - 3301.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Cazzola, A. May, G. Bergamaschi, P. Cerani, V. Rosti, and D. F. Bishop
Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females
Blood, December 15, 2000; 96(13): 4363 - 4365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Jang and L. Mao
Methylation Patterns in Human Androgen Receptor Gene and Clonality Analysis
Cancer Res., February 1, 2000; 60(4): 864 - 866.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vottero, C. A. Stratakis, L. Ghizzoni, C. A. Longui, M. Karl, and G. P. Chrousos
Androgen Receptor-Mediated Hypersensitivity to Androgens in Women with Nonhyperandrogenic Hirsutism: Skewing of X-Chromosome Inactivation
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1091 - 1095.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.